Richard G Pebody
Overview
Explore the profile of Richard G Pebody including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1084
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mesle M, Brown J, Widdowson M, Pebody R
Lancet Respir Med
. 2024 Dec;
13(1):e5.
PMID: 39675360
No abstract available.
2.
Vestergaard L, Pebody R
Lancet Reg Health Eur
. 2024 Sep;
45:101053.
PMID: 39279870
No abstract available.
3.
Ikejezie J, Miglietta A, Hammermeister Nezu I, Adele S, Higdon M, Feikin D, et al.
BMJ Glob Health
. 2024 Apr;
9(4).
PMID: 38580376
On 31 December 2019, the Municipal Health Commission of Wuhan, China, reported a cluster of atypical pneumonia cases. On 5 January 2020, the WHO publicly released a Disease Outbreak News...
4.
Sinnathamby M, Warburton F, Reynolds A, Cottrell S, ODoherty M, Domegan L, et al.
Influenza Other Respir Viruses
. 2023 Feb;
17(2):e13099.
PMID: 36824392
Background: The universal paediatric live attenuated influenza vaccine (LAIV) programme commenced in the United Kingdom (UK) in 2013/2014. Since 2014/2015, all pre-school and primary school children in Scotland and Northern...
5.
Funk T, Innocenti F, Gomes Dias J, Nerlander L, Melillo T, Gauci C, et al.
Euro Surveill
. 2022 Sep;
27(35).
PMID: 36052721
BackgroundUnderlying conditions are risk factors for severe COVID-19 outcomes but evidence is limited about how risks differ with age.AimWe sought to estimate age-specific associations between underlying conditions and hospitalisation, death...
6.
Boddington N, Elgohari S, Ellis J, Donati M, Zambon M, Pebody R
Influenza Other Respir Viruses
. 2022 May;
16(5):937-941.
PMID: 35585686
Introduction: The use of rapid molecular testing for influenza diagnosis is becoming increasingly popular. Used at the point of care or in a clinical laboratory, these tests detect influenza A...
7.
Boddington N, Mangtani P, Zhao H, Verlander N, Ellis J, Andrews N, et al.
Influenza Other Respir Viruses
. 2022 May;
16(5):897-905.
PMID: 35531630
Introduction: In 2013, the United Kingdom began to roll-out a universal annual influenza vaccination program for children. An important component of any new vaccination program is measuring its effectiveness. Live-attenuated...
8.
Birrell P, Wernisch L, Tom B, Held L, Roberts G, Pebody R, et al.
Ann Appl Stat
. 2022 Jan;
14(1):74-93.
PMID: 34992706
A prompt public health response to a new epidemic relies on the ability to monitor and predict its evolution in real time as data accumulate. The 2009 A/H1N1 outbreak in...
9.
Mesle M, Brown J, Mook P, Hagan J, Pastore R, Bundle N, et al.
Euro Surveill
. 2021 Nov;
26(47).
PMID: 34823641
Since December 2019, over 1.5 million SARS-CoV-2-related fatalities have been recorded in the World Health Organization European Region - 90.2% in people ≥ 60 years. We calculated lives saved in...
10.
Muller-Pebody B, Sinnathamby M, Warburton F, Rooney G, Andrews N, Whitaker H, et al.
Vaccine
. 2021 Oct;
39(45):6622-6627.
PMID: 34627625
Vaccines are a key part of the global strategy to tackle antimicrobial resistance (AMR) since prevention of infection should reduce antibiotic use. England commenced national rollout of a live attenuated...